We have developed a medium-term bioassay system of 8 weeks duration utilizing male Fisher 344 (F344) rats for detection of liver carcinogens and modifiers of hepatocarcinogenesis. The system consists of a single intraperitoneal injection of diethylnitrosamine (DEN, 200 mg/kg), 6-weeks-administration of test chemical beginning 2 weeks after the DEN injection, and VI partial hepatectomy (PH) performed at week 3. Carcinogenic potency of test chemicals is predicted based on the results of quantitative analyses of immunohistochemicallydemonstrated glutathione S-transferase placental form (GST-P) positive liver cell foci. At present, a total of 140 chemicals have been tested using this system, and the findings show a good correlation with reported carcinogenic activities in long-term tests. Furthermore, the reliability of the system has been extensively examined: the results from the medium-term bioassay were compared with those from long-term experiments using the same doses of selected chemicals; the data from presently-used 2-dimensional analysis were compared with calculated values utilizing mathematical formulae for three-dimensional analysis: conformity of phenotypic expression of enzymes in preneoplastic lesions was examined in relation to their growth activity. In conclusion, although the results with non-hepatocarcinogens were less than satisfactory, the present experimental protocol, which requires far fewer animals and shorter duration than a long-term carcinogenicity test, appears of advantage for rapid screening of the large number of environmental chemicals which may possess hazard potential for induction of liver cancer in man. placental form of glutathione S-transferasc; IQ: 2-amino-3-rnethylimidazo(4,5-Qquinoline; 3'-Me-DAB: 3'-methyl-4-dimethylaminoazobenzene; mEHb microsomal epoxide hydmse with broad substrate specificity; MNNG: N-methyl-N-nitro-N-nitrosoguanidine; PB: phenobarbital; P H % partial hepatectomy.
INTRODUCTION
vironmental carcinogenic agents, partly as a reflection of individual life-style (2, 5,43). Investigation in animal experiments has further established that a variety of compounds are capable of playing a role Epidemiologial studies have demonstrated that are mused by exposure to enmost human in tumongenesis, and it is now recognized that detection and appropriate regulation of these compounds are of prime importance for the prevention testing using rodents has been considered to be the most reliable method for prediction of carcinogenic potential in man (1 5 , 30) . However, long-term tests must satisfy costly regulatory guidelines for appropriate facilities, long duration (2 yr) maintenance of animals, sufficiently large numbers of animals and careful histopathologi~l examination. The vast number of compounds which have been introduced into our environment in recent years is thus far beyond our capacity to assess using such comprehensive carcinogenicity in vivo tests in each case. A large number of short-term in vitro assays has been developed with the aim of predicting the carcinogenicity of test compounds within a short period, and thus facilitating mass screening of compounds. Although the majority of the systems are very rapid and economical, the validity of these in vitro short-term tests is limited by substantial rates of false negative and false positive determinations (in comparison with long-term in vivo bioassays) and by their inability to determine target organspecific chemical carcinogenicity or promoting activity (11, 17, 21, 27) . In our laboratory, attention has been focused for several years on the development of in vivo mediumterm bioassay systems using the rat liver. Since the liver is the target organ of 33 out of 65 carcinogens (52%) which have been evaluated by IARC (16) and 80 out of 149 carcinogenic compounds (67%) evaluated by long-term studies for carcinogenicity sponsored by the National Cancer Institute and the National Toxicology Program (44) , the conclusion that it is the best organ in which to assess carcinogenicity in bioassay systems appeared to be warranted. Fig. 1 shows the protocol now employed in our laboratory for medium-term bioassays. Male F344 male rats are divided into 3 groups; Group 1 is given a single ip injection of DEN (200 mghg) dissolved in 0.9% NaCl to initiate hepatocarcinogenesis and, after 2 weeks recovery period, receives one of the test compounds in the basal diet, drinking water, or by repeated ip or iv injections. Animals are subjected to PH at week 3 to maximize any interaction between proliferation and the modification effects of the compounds tested. Group 2 is given DEN and PH in the same manner as for Group 1 without administration of any test compounds. Group 3 rats are injected with 0.9Oh NaCl instead of DEN solution and then subjected to administration of test compound and PH. All animals are sacrificed at week 8, and immediately upon killing, the liver is excised and sections 2-3 mm thick are cut with a razor blade. Four slices, one each from the right posterior and caudate lobes and 2 from the right anterior lobe, are fixed in ice-cold acetone solution for immunohistochemical examination of GST-P.
Protocol of the Medium-Term Bioassay Model (DEN-PH Model) for Carcinogens
Additional sections are fixed in 10% phosphatebuffered formalin solution for routine staining with hematoxylin and eosin (H&E). The avidin-biotin-peroxidase complex (ABC) method described by Hsu et a1 (14) is used to demonstrate GST-P positive liver cells. After deparaflinization, liver sections are treated sequentially with normal goat serum, rabbit anti-GST-P (1:8,000), biotin-labeled goat anti-rabbit IgG (1 :400) and ABC. The sites of peroxidase binding are demonstrated by the diaminobenzidine method ( Fig. 2 ). Sections are then counter-stained with hematoxylin for microscopic examination. As a negative control for the specificity of anti-GST-P antibody binding, pre-immune rabbit serum is used instead of antiserum.
The numbers and the areas of GST-P positive foci of more than 0.2 mm in diameter arc measured using a color vidco image proccssor (VIP-2 IC) (25) and the rcsults arc asscsscd by comparing the values of foci between Group I (DEN-test compounds) and Group 2 (DEN alone). Group 3 scrvcs to assay the potcntial of the tcst chemicals to inducc GST-P positive foci without prior DEN.
Statistical analysis is carricd out using the Student's t-test and Cochran's 1-test in combination with thc F-test for variability (9) and scoring of carcinogenicity, promotion or inhibition is made on the basis of diffcrenccs in P-values between Groups 1 and 2: positive = incrcasc at I' .
. 0.05 in either number or arca of foci.
Trial qf 140 ('hcniiculs i n thc Prcscnt .S~:stcn~ A total of 140 chemicals have alrcady bcen analyzcd using this medium-tcrm bioassay system in our laboratory. Tcst chcmicals arc classified into 4 categories: hcpatocarcinogcns: carcinogens othcr than hepatocarcinogcns; non-carcinogens: and chcmicals for which carcinogenicit> had not prcviously been c\.aluatcd. Similarly. the compounds arc divided into 3 groups according to their gcnotoxicity mainly bawd on rcponcd rcsults in Amcs' t cs t : gc no t o x i c co m pounds. n on -gc n o t o x ic compounds and unknowns. Data for 1 I2 chcmicals have bcen published pre\~ousl! ( 7 6 ) and Tablc I summarizcs results for thc 1-10 chcmicals so far cxamincd. along with findings for carcinogcnic and gcnotoxic activitics. whcrc a\,ailablc.
It is especially noteNorth! that 7? of 30 (93%) hcpatocarcinogcns ga\.c positivc results. irrcspectivc of their gcnotoxicii!. Ica\.ing only 3 compounds. 4.4'-diaminodiphcn!lmcthanc (DDPM). di(~-cthylhex~~l)phthalatc (DEHP) and clofibratc, as falsc negatives. DIIPM. a potcnt aromatic hepatotoxic agcnt. which induccs marked hilc duct prolifcration in the li\.cr. was previously rcportcd to inhibit induction of tumors in the livcr. kidncy and urinary bladdcr (8) . DEHPand clofibratc arc known as pcroxisomc prolifcrating agcnts. Both arc non- Thirteen out of 20 compounds that arc ncgativc in thc Anics' tcst and positive in thc prcscnt system have bccn rcportcd to be carcinogcns. These include estrogenic hormonal agcnts. chlorinated pcsticides. hepatotoxic agcnts. and hepatic microsomal enzyme inducers among othcrs. Most important is the fact that nonc o f thc conipounds currently considcrcd as non-carcinogcns pro\'cd positive. In other words, the bioassay system did not gcncratc falsc-positive rcsults. an essential advantage for practical use.
This assay systcni also posscsscs the advantage that detection of inhibiton. agcnts for hcpatocarcinogcncsis is possible. The majority of compounds which showed inhibitory effects were non-gcnotoxic agcnts and non-carcinogcns. 1 I of thcsc 24 chemicals being antioxidants ( 3 . 13. 18. 26. 28. 40). Results for I36 chemicals wcrc alrcady rcportcd ( 2 3 ) .
C 'ornparison bet ween Mediunr-7crm Bioassay .Yj*.stctli atid Lotig-Tcrt,i ( b r c . i t i o~~( I t i i c . ; t j . 7 i w R(~sirlts
Two experiments h a w bccn pcrformcd to validate the prcdictivity of the syctcm by comparison with results from long-term studies. E.vj)(>rimwt 1. The dosc-dcpcndcnt cflects ofthree hepatocarcinogens wcrc investigated by measuring thc number and area of GST-P positivc foci and nodules appearing in the liver in our medium-term bioassay system and comparing with the incidence of hepatocellular carcinoma after long-term chronic administration (32). Fig. 3 illustrates the protocols uscd for thcsc cxpcriments.
Three different doscs of 2-acctylaminofluorene single injection of DEN in the medium-term bioassay or for 104 weeks without initiation by DEN in a long-term carcinogenicity test. The results of these comparative studics are summarized in Fig. 4 . The induction of GST-P positive foci and nodules by 2-AAF and 3I-Me-DAB was clearly dose-dependent. In the DL-cthioninecase. only the highest dose group demonstrated significant numbers of lesions. Similarly, in the long-term carcinogenicity test, induction of hepatocellular carcinomas by 2-AAF and 3'-Mc-DAB was clearly dosc-dependent. whereas liver neoplasms were only induced by the highest dose level of DL-ethionine. These results clearly indicated that the degree of induction of GST-P positive foci and nodules in the medium-term bioassay system for liver carcinogens corresponds with the incidences of hepatocellular carcinomas as revealed in long-term assays. Experimenf 2. The effects of hepatocarcinogens (DL-ethionine. thioacetamide, phenobarbital(PB)), non-hepatocarcinogens (N-ethyl-N-(4-hydroxybu-ty1)nitrosamine (EHBN). N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)) and a hepatoinhibitor (butylated hydroxyanisole (BHA)) were investigated in the medium-term bioassay ( Fig. 5 ) and the eventual incidence of hepatocellular carcinomas evaluated by following up lesion development after application of the medium-term bioassay for a long period wilh and uithout cxtcndcd test chemical administration. Each chcmical was givcn to male F344 rats for 6 wecks. starting 2 weeks after a single injcction of DEN. In thc long-tcrm study. animals were treated in thc samc manner as abovc. but then were givcn basal dict and tap watcr (Group 3) or each chemical continuously (Group 4 ) for up to 104 weeks. In Group 1. all hcpatocarcinogens enhanced thc induction of GST-P-positive foci ( Table 11 ). In contrast. non-hcpatocarcinogens showed no effects on the dcvclopmcnt of GST-P positive foci. Similarly. in the long-tcrm study. induction of hepatocellular carcinomas was clearly enhanced by hepatocarcinogens in both Groups 3 and 4. However. while DL-ethioninc in Group 3 incrcascd the incidence of hepatocellular carcinomas. the effect was not statistically significant. BHA showed a tendency to inhibit development of hepatocellular carcinomas. None of the non-hepatocarcinogens atfected thc development of hepatocellular carcinomas and only induced cancers in their own target organs, such as urinary bladder for EHBN and glandular stomach adenocarcinoma for MNNG. These results again indicate that degree of induction of GST-P positive foci in the medium-term bioassay for liver carcinogens corrcsponds with the incidences of hepatocellular carcinomas resulting after long term irt v i w observation ( Table Ill) . 
No. of GST-P+foci

Assessment of Three-Dimensional GST-P Positiw Focirs Qirarititatiw C'alucs
The applicability of mathematical formulae for the calculation of numbers of foci per volume was examined by graphic three-dimensional reconstruction of the shape of individual GST-P positive foci (20) since some authors have strongly recommended transformation of data gained from two-dimensional sections for accurate evaluation of preneoplastic liver lesion development (4, 6).
GST-P positive foci were induced by the DEN-PH protocol. As test chemicals, liver carcinogens of different potency, N-ethyl-N-(4-hydroxyeth-y1)nitrosamine (EHEN, 0.05% in drinking water), dibutylnitrosamine (DBN, 0. l0h in drinking water), aldrin (0.005°h in diet), and PB (0.05% in diet), and an inhibitory agent, BHA (29'0 in diet) were used. Liver was serially sectioned and immunohistochemically stained with GST-P at 10 to 15 pm steps (every 3-4 sections) for up to 150 sections.
Numbers and areas of GST-P positive foci were measured as for a normal assay study and quantitativc values for GST-P positive foci calculated using formula introduced for liver models by Campbell et al (4), and Enzmann's formula (6) . The resultant numbers of GST-P positive foci/cm? and calculated numbers of foci/liver for each ofthe compounds are compared in Fig. 6 . It is clear that the promoting potentials of EHEN. DBN. aldrin and PB or inhibition by BHA are equally expressed either as numbers of foci per cm! or per liver. irrespective of which formula is employed.
Stereological reconstitution of GST-P positive foci or nodules which were three-dimensionally reconstructed using a computer graphic system showed that the shape of GST-P positive foci is not always spherical but rather irregular branching forms as typically demonstrated in Fig. 7 .
The results thus clearly showed that both twoand three-dimensionally expressed quantitative data adequately represent the modifying potential of test chcmicals. Since calculation of three-dimensional values is based on the partially false assumption that foci are spherical, assessment of focus dcvclopment from two-dimensional data may be more accurate (20) . P,cncIc'l'lu.stil. 1-c.si0ti .v atid Its Kclurioti io (iro\\*tli ..lcti\*iti* Among the wide variety of enlymcs which demonstratc altcration in prcncoplastic populations in-cluding GGT. adcnosine triphosphatase (ATPase), glucosc-6-phosphatasc and glucosc-6-phosphate dehydrogcnasc (G6PD) ( 1 . 7) . G G T has bcen most widcly used for quantitation (10. 12) . The othcrs suffcr from methodological disadvantages which preclude thcir use for analysis of very large numbers of samplcs. and G G T staining also suffers from a disadvantagc. namcly that of high background stain- enzyme (34). GST-P positive cells can easily be demonstrated in acetone-fixed paraffin embedded sections by immunohistochemical technique. Although GST-P is slightly induced by RHA or BHT in the periportal hepatocytes, this was found to be at a much lesser extent than GGT and all GST-P foci were clearly distinguishable (Fig. 2) . More recent studies have confirmed GST-P positivity as suitable for recognition of all cellular stages in hepatocarcinogenesis (36) (37) (38) . Single GST-P positive liver cells have been also proposed as initiated liver cells (29). Therefore. we introduced GST-P as a novcl end-point marker enzyme in our assay system (38). Expression of multiple enzyme phenotypes of putative preneoplastic cells and their surrounding hepatocytes which were induced using the present protocol was assessed (4 I ). The levels ofGST-P. G6PD. GGT, ATPase, PB-inducible cytochrome P-450 (P-450PB,,). and microsomal epoxide hydrolase with broad substrate specificity (m EH b) were corn pared along with cellular proliferation which was monitored by the incorporation of brornodeoxyuridine (BrdU) into the nuclei of hepatocytes.
I'lwnotjpic L'.vprc.s.sioti c!f f;ti:jwic.s it1
As test chemicals, 4 chemicals that are known liver tumor modifying agents were used: 2-amino-3-methylimidazo (4,543 quinoline (IQ). PB. BHA and DEHP. BrdCl was pcrfuscd during the last week (wcck 8) using an osmotic minipump implanted subcutaneously. The livers were immediatcl) frozen in isopentanc or fiscd in ice-cold acctonc. Serial sections were cut on a cpostat for the histochemical demonstration of (i6PD. XTPase and GGT and immunohistochcmical demonstration of GST-P. P-45OPB,,. mEHb and incorporated BrdlJ. Typical staining patterns of livcr foci for these cnlymcs are shown in Figs. 3 and 8 .
Quantitative values (number cm') wcre largest in IQ-treated rats. followcd by the PB-treated group. BHA and DEHP clearly inhibited the induction of foci positive for GST-P. G6PD and GGT. or negative for ATPasc. Values for the numbers of BrdlJ positive foci (more than 5O0~n of cclls in foci stained positive) constituted approximately 20-4On/o of the individual values for GST-P. G6PD. GGT and ATPase. The conformity class distribution clearly showed that total foci counted dccrcascs as the number of conforming cnzymes increases. In contrast. the incidence of BrdlJ' foci conforming with the other 6 enzyme phenotypes clearly increased along with the number ofconforming phcnotypes. Among the foci expressing a 3 enzyme phenotyw. combination of GST-P + G6PD gavc the largest number. Obvious increases in thc incidence of HrdU' foci among the higher range of conformity ( 4 4 phenotypes) strongly indicate that multiple expression of different phenotypes within individual lesions might be closely related to the potential for neoplastic proliferation (Fig. 9 ).
DISCUSSION
It is proposed that the present experimental protocol, which requires far fewer animals and shorter duration than a long-term carcinogenicity test, is of advantage for rapid screening of the large number of environmental chemicals which may possess hazard potential for induction of liver cancer in man. The marker of liver cell foci used in the present protocol was GST-P, which has been demonstrated to be a reliable marker of preneoplastic liver lesions. Methodologically, this marker enzyme may be the best for mass screening of a vast number of environmental chemicals since paraffin-embedded section is available. Although the results with nonhepatocarcinogens were less than satisfactory, the system could nevertheless be of practical use because more than 60Yo of the environmental carcinogens which were rated to have 'sufficient evidence' ofcapacity to cause cancer in man listed in the IARC proved to be hepatocarcinogens.
For the rapid detection of carcinogenic potential of environmental compounds, various in vivo experimental systems have been developed. In the liver system proposed by ourselves, although the vast majority of liver carcinogens proved positive, others belonging to particular categories, like the peroxisome proliferators, could not be detected (26, 31, 33, 42) . Since the proliferation of peroxisomes in hepatocytes presumably acts in a distinctly different way from the genotoxic effects induced by clearly genotoxic chemical carcinogens this may be responsible for the observed variation in altered gene expression.
The in vivo medium-term bioassay for screening environmental carcinogens described here is one promising approach, and preliminary data have suggested that the addition of further steps might increase the sensitivity of the system (22). Since the 2-step liver assay model (DEN-PH model) is based on the induction of preneoplastic hepatocyte lesions, it primarily provides information on whether a test compound is carcinogenic to the liver. For detecting carcinogenic agents active in other tissues in a relatively short period, wide spectrum organ models employing sequential treatment with several carcinogens may offer the best approach (24).
In conclusion, our data indicate that a judicious blend of liver and wide spectrum bioassay systems may be most effective for the detection of chemicals of potential hazard to man. 
